BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldwin DS, Hou R, Gordon R, Huneke NT, Garner M. Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets. CNS Drugs 2017;31:307-17. [PMID: 28303465 DOI: 10.1007/s40263-017-0423-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo L. Effect of Marxist ideological and political education on students’ anxiety in colleges and universities. Front Psychol 2022;13:997519. [DOI: 10.3389/fpsyg.2022.997519] [Reference Citation Analysis]
2 Huneke NT, Rowlatt H, Hyde J, Mcewan A, Maryan L, Baldwin DS, Garner M. A Novel Procedure to Investigate Social Anxiety using Videoconferencing Software: A Proof-of-Concept study. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114770] [Reference Citation Analysis]
3 Jiang SS, Liu XH, Han N, Zhang HJ, Xie WX, Xie ZJ, Lu XY, Zhou XZ, Zhao YQ, Duan AD, Zhao SQ, Zhang ZC, Huang XB. Effects of group mindfulness-based cognitive therapy and group cognitive behavioural therapy on symptomatic generalized anxiety disorder: a randomized controlled noninferiority trial. BMC Psychiatry 2022;22:481. [PMID: 35854250 DOI: 10.1186/s12888-022-04127-3] [Reference Citation Analysis]
4 Burtscher J, Niedermeier M, Hüfner K, van den Burg E, Kopp M, Stoop R, Burtscher M, Gatterer H, Millet GP. The interplay of hypoxic and mental stress: Implications for anxiety and depressive disorders. Neurosci Biobehav Rev 2022;138:104718. [PMID: 35661753 DOI: 10.1016/j.neubiorev.2022.104718] [Reference Citation Analysis]
5 Baldwin DS. Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications. Addiction 2022;117:1472-82. [PMID: 34542216 DOI: 10.1111/add.15695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zemestani M, Beheshti N, Rezaei F, van der Heiden C, Kendall PC. Cognitive Behavior Therapy Targeting Intolerance of Uncertainty Versus Selective Serotonin Reuptake Inhibitor for Generalized Anxiety Disorder: A Randomized Clinical Trial. Behav change 2021;38:250-62. [DOI: 10.1017/bec.2021.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dal-Pizzol F, de Medeiros GF, Michels M, Mazeraud A, Bozza FA, Ritter C, Sharshar T. What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review. Neurotherapeutics 2021. [PMID: 33410107 DOI: 10.1007/s13311-020-00981-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dalton B, Leppanen J, Campbell IC, Chung R, Breen G, Schmidt U, Himmerich H. A longitudinal analysis of cytokines in anorexia nervosa. Brain, Behavior, and Immunity 2020;85:88-95. [DOI: 10.1016/j.bbi.2019.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xie ZJ, Han N, Law S, Li ZW, Chen SY, Xiao JP, Zhang Y, Gao BL, Jiang SS, Gao HM, Huang XB. The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone. Acta Neuropsychiatr 2019;31:316-24. [PMID: 31405402 DOI: 10.1017/neu.2019.32] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Reis CG, Mocelin R, Benvenutti R, Marcon M, Sachett A, Herrmann AP, Elisabetsky E, Piato A. Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish. Naunyn Schmiedebergs Arch Pharmacol 2020;393:591-601. [PMID: 31768573 DOI: 10.1007/s00210-019-01762-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Zhang J, He Y, Jiang X, Jiang H, Shen J. Nature brings new avenues to the therapy of central nervous system diseases—An overview of possible treatments derived from natural products. Sci China Life Sci 2019;62:1332-67. [DOI: 10.1007/s11427-019-9587-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Grillon C, Robinson OJ, Cornwell B, Ernst M. Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences. Neuropsychopharmacology 2019;44:1999-2010. [PMID: 31226707 DOI: 10.1038/s41386-019-0445-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
13 Shen Z, Zhu J, Yuan Y, Ren L, Qian M, Lin M, Cai M, Zhang Z, Shen X. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder. Psychiatry Research 2019;271:319-24. [DOI: 10.1016/j.psychres.2018.08.111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
14 Dalton B, Whitmore V, Patsalos O, Ibrahim MAA, Schmidt U, Himmerich H. A systematic review of in vitro cytokine production in eating disorders. Mol Cell Endocrinol 2019;497:110308. [PMID: 30296466 DOI: 10.1016/j.mce.2018.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Dalton B, Bartholdy S, Robinson L, Solmi M, Ibrahim MAA, Breen G, Schmidt U, Himmerich H. A meta-analysis of cytokine concentrations in eating disorders. J Psychiatr Res 2018;103:252-64. [PMID: 29906710 DOI: 10.1016/j.jpsychires.2018.06.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 15.3] [Reference Citation Analysis]
16 Gomez AF, Barthel AL, Hofmann SG. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opin Pharmacother 2018;19:883-94. [PMID: 29806492 DOI: 10.1080/14656566.2018.1472767] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]